You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis C Genotype 2

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

Completed
Has Results
  • Hepatitis C Infection
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)

Recruiting
  • Acute Coronary Syndrome
  • CYP2C19 Polymorphism
  • Nieuwegein, Utrecht, Netherlands
    St. Antonius Hospital
Jun 27, 2023

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • (no location specified)
    Jul 8, 2021

    Hepatitis C, Chronic Trial (Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c)

    Completed
    • Hepatitis C, Chronic
    • Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
    • Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
    • (no location specified)
    Aug 24, 2020

    Hepatitis C Virus Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    Hepatitis C, Chronic Trial in Carlsbad (ISIS 14803)

    Completed
    • Hepatitis C, Chronic
    • ISIS 14803
    • Carlsbad, California
      Isis Pharmaceuticals
    Dec 1, 2022

    Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)

    Not yet recruiting
    • Atrial Fibrillation
    • Coronary Artery Disease
    • (no location specified)
    Oct 22, 2023

    HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)

    Completed
    • HCV
    • Beijing, Beijing, China
      Peking University People's hospital
    Jul 25, 2020

    Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
    • Phoenix, Arizona
    • +47 more
    Jun 27, 2022

    Chronic Hepatitis C Virus Infection Trial in New Zealand, United States (telaprevir, VX-222, ribavirin)

    Terminated
    • Chronic Hepatitis C Virus Infection
    • La Jolla, California
    • +20 more
    Sep 22, 2020

    Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

    Terminated
    Has Results
    • Hepatitis C
    • Simeprivir (SMV)
    • +2 more
    • Denver, Colorado
      University of Colorado Denver (Leprino Building)
    Aug 16, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin (RBV)
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 29, 2021

    Chronic Hepatitis c, Liver Transplant Infection, Kidney Transplant Infection Trial in Taichung (grazoprevir 100 mg/ elbasvir 50

    Terminated
    • Chronic Hepatitis c
    • +2 more
    • grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®
    • Taichung, Taiwan
    • +1 more
    Mar 14, 2021

    Australian Hepatitis and Risk Survey in Prisons

    Recruiting
    • Hepatitis C
    • +2 more
    • Point-of-care hepatitis C antibody test
    • +5 more
    • Hume, Australian Capital Territory, Australia
    • +23 more
    Apr 20, 2023

    Hepatitis C Trial in Worldwide (telaprevir, ribavirin, peginterferon alfa-2a)

    Completed
    Has Results
    • Hepatitis C
    • Birmingham, Alabama
    • +81 more
    Mar 3, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 8, 2021

    Hepatitis C Virus Infection Trial (SOF/RBV/PegINFa-2)

    Completed
    • Hepatitis C Virus Infection
    • (no location specified)
    May 6, 2020

    Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

    Recruiting
    • Chronic Hepatitis C Virus
    • +4 more
    • Bucuresti, BUC, Romania
      Atea Study Site
    Jun 15, 2023